Acadia stockholders approve 6M share increase for equity plan, elect directors

ACADIA PHARMACEUTICALS INC

Stockholders approved amendment to 2010 Equity Incentive Plan, increasing authorized shares by 6,000,000 (135.2M for, 6.6M against).
Class III directors Laura A. Brege, Stephen R. Davis, and Elizabeth A. Garofalo elected with 89.4M, 127.1M, and 117.4M votes for, respectively.
Advisory vote on executive compensation approved (127.2M for, 3.4M against).
Ratification of Ernst & Young as independent auditor for FY2022 passed (141.5M for).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.